| Antibiotic Resistance in Bacteria | Lifetime | 86 | TW 2 | 99.67 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 80 | TW 2 | 99.44 |
| Antibiotic Use and Resistance | Lifetime | 80 | TW 2 | 99.36 |
| COVID-19 Clinical Research Studies | Lifetime | 333 | TW 5 | 98.60 |
| Vibrio bacteria research studies | Lifetime | 102 | TW 2 | 99.09 |
| Aquaculture disease management and microbiota | Lifetime | 293 | TW 6 | 98.49 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 207 | TW 6 | 98.88 |
| Pneumonia and Respiratory Infections | Lifetime | 381 | TW 3 | 98.63 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 674 | TW 11 | 97.83 |
| Urinary Tract Infections Management | Lifetime | 340 | TW 4 | 97.69 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 344 | TW 1 | 97.42 |
| Infections and bacterial resistance | Lifetime | 71 | TW 3 | 96.57 |
| Streptococcal Infections and Treatments | Lifetime | 622 | TW 9 | 96.87 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 833 | TW 11 | 96.68 |
| Nosocomial Infections in ICU | Lifetime | 374 | TW 4 | 96.56 |
| Salmonella and Campylobacter epidemiology | Lifetime | 808 | TW 7 | 95.87 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 219 | TW 2 | 94.67 |
| Microscopic Colitis | Lifetime | 955 | TW 2 | 95.69 |
| Amoebic Infections and Treatments | Lifetime | 446 | TW 11 | 93.12 |
| Infectious Aortic and Vascular Conditions | Lifetime | 959 | TW 6 | 87.61 |
| Burkholderia infections and melioidosis | Lifetime | 739 | TW 9 | 71.86 |
| Antibiotic Use and Resistance | 2021-2025 | 81 | TW 2 | 97.76 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 224 | TW 2 | 97.04 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 95 | TW 2 | 96.41 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 115 | TW 2 | 95.91 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 151 | TW 2 | 93.72 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 453 | TW 1 | 92.81 |
| Streptococcal Infections and Treatments | 2021-2025 | 178 | TW 5 | 91.43 |
| Pneumonia and Respiratory Infections | 2021-2025 | 461 | TW 5 | 92.01 |
| Microscopic Colitis | 2021-2025 | 554 | TW 3 | 91.55 |
| Urinary Tract Infections Management | 2021-2025 | 399 | TW 17 | 85.98 |
| Nosocomial Infections in ICU | 2021-2025 | 279 | TW 3 | 84.98 |
| Enterobacteriaceae and Cronobacter Research | 2021-2025 | 217 | TW 6 | 68.80 |
| Escherichia coli research studies | 2021-2025 | 933 | TW 11 | 62.11 |
| Infections and bacterial resistance | 2021-2025 | 259 | TW 23 | 60.54 |
